Article
Antitrust And Competition Life Sciences Quarterly Update Q2 2024
To date, 2024 has not yet seen the type of mega-merger (Pfizer/Seagen) or level of agency enforcement (Sanofi/Maze or Amgen/Horizon) as 2023. But two notable investigations — one still active — show...
Goodwin Procter LLP